B2Core’s New iOS Update That Traders Have Been Waiting For - Why It Matters?
In its strive to deliver the best customer relationship management tools and innovations, B2Core raises the bar with a new update onboarding the renowned cTrader trading software.
The new V1.20 iOS mobile update saw the revamping of user experience and layout design, making trading easier and more functional for traders of all types. This update sets a new standard for B2Core’s comprehensive services, bringing more tools to the user’s hands.
cTrader x B2Core
cTrader is a popular trading software used by several service providers and key players in the industry. Most brokerage firms and large financial institutions include cTrader in their offering as a reliable trading arm.
The software is known for its simplicity and high functionality, incorporating the most recent trading tools and trends like copy trading and other automated trading models to attract traders of all experiences. The data focus and in-depth market analysis are what set cTrader apart from other trading platforms in the market, besides its commitment to understanding and serving user’s demands in the best possible way.
Many traders prefer cTrader because it is easy to use and includes a variety of asset classes and securities.
What Can Users Expect From The New B2Core Update?
Users are going to love this update because of the many updates and changes it provides.
New Trading Experience
The update combined the best of both worlds, B2Core and cTrader, to provide the most robust tools and CRM technologies for the user. Monitoring the market and executing different market orders have been simplified with a straightforward user interface.
Traders can now do everything in one place, such as registering, passing KYC, transferring funds and more on any trading software, whether MT or cTrader. The merger brings more news analysis, market insights and charting options and functions directly on the app without switching between cTrader and B2Core this time, making the user’s experience easier.
More Tradables With Better Liquidity
Traders can find more CFD offerings in several markets, including stocks, commodities or indices, where traders can diversify their portfolios.
The update takes advantage of B2Broker’s liquidity service across more than 1,000 financial instruments and securities to explore more options to trade and gain in the financial markets.
Beyond the standard forex offerings, the added support for CFD asset class trading opens up a new world of trading opportunities for our users. Whether it's commodities, indices, or stocks, traders have a diverse range of assets to choose from.
Financial Outcome Update
The update brings a new feature that matters to every trader: real-time profit & loss update, showing the outcomes of every trading decision and market order on the trader’s financial well-being.
Traders can now receive timely market information and insights that help make informed market decisions using data-focused newsfeeds.
Easier Account Configuration
Users can now find more tools in their account settings, with simplified functionality for depositing and executing trades. Account management is now better, with faster deposits and withdrawals to ensure quick execution and timely decisions.
Revamped App With an Improved UX
Despite the tremendous arrival of cTrader to the B2Core app, there are other fascinating features on the app.
The new update includes performance enhancements with improved design on widgets and tools. The “trading pairs” function is part of the update. Users can also see limits when depositing or withdrawing funds according to the given currencies, focusing on service transparency.
Updates also included MetaTrader software, specifically on the calendar and ticket management of the Helpdesk on MT4/5. Users can now have more clarity on the tickets they issued and monitor the customer support process.
The new B2Core iOS app update brings a whole new perspective to trading and CRM technology, onboarding cTrader to its platform and integrating more tools and functions to make the user experience smoother.
The new features aim to make the trading experience seamless, bundling all services in one place, supported by various analytical tools that every trader seeks.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
+44 208 068 8636
About Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
VIOOH Shares Industry-first Carbon Emissions Measurement Hitting 18% Below Benchmark11.12.2023 09:00:00 CET | Press release
Today, VIOOH, the leading premium global digital out of (DOOH) home supply-side platform, announced a partnership with the Carbon Intelligence Platform, Cedara, a supporter of Ad Net Zero. In an industry first for a programmatic DOOH (prDOOH) player, VIOOH has shared publicly its impression intensity carbon emissions (grams CO2e) per ad impression for 2022, which is 18% below the programmatic open web benchmark. Based on Cedara’s measurement, VIOOH generated 0.28 grams CO2e per ad impression in 2022, well below the Cedara ad platform benchmark of 0.34, which is based on programmatic open web vendor data. VIOOH worked closely with Cedara on a comprehensive greenhouse gas (GHG) inventory assessment across its operations, including programmatic media activity, which contributes the majority of Scope 3 emissions. As part of its measurement process, Cedara not only analysed data sets from business operations, but also activity data from media delivery, data centres, and media owners, amongs
Hexadrone Starts C5 and C6 Drone Type Examination After Successful GAP Analysis of The TUNDRA 2’ Specification by Notified Body11.12.2023 08:30:00 CET | Press release
Hexadrone SAS, A French Modular UAV’s Manufacturer Created in 2014 has successfully completed GAP Analysis for The Tundra 2 in its Urban and Endurance versions versus DR EU 2019/945 with intension for Class Identification Label C5 and C6. With the achievement of this milestone, the certification process for both Urban and Endurance Version have been now formally triggered by Hexadrone to be performed by the notified body NavCert GmbH. The Tundra 2 is bringing on the market a key differentiator by providing extreme modularity on UAVs, integrating unlimited type of payloads used in various sectors like, Surveillance, Geospatial, Agriculture, Oil and gas, Military, Homeland security, Rescue and much more. “Through an in-depth analysis based on European Union (EU) Regulation 2019/945, we have ensured that the specifications of the Tundra 2 as well as our user manuals fully meet the current requirements. This compliance will ensure that the TUNDRA 2 users will be able to fly in European air
VINSSEN Co., Ltd. Successfully Supplies Hydrogen Fuel Cell for Industry Project in Singapore11.12.2023 08:00:00 CET | Press release
VINSSEN Co., Ltd. (CEO Chil-Han Lee), a company specializing in the production of electric and hydrogen hybrid propulsion systems, has successfully tested and delivered a hydrogen fuel cell system for a trial project involving several key industry partners. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231210481971/en/ Hydrogen fuel cell power generation equipment is undergoing inspection before delivery (Photo: VINSSEN Co., Ltd.) VINSSEN is collaborating with Shell Singapore Pte. Ltd. (Shell) as the project sponsor, Seatrium Limited as the project developer, Penguin International Limited as the owner and operator of the vessel, and Air Liquide Singapore Private Limited as the hydrogen supplier. This project is a pilot to test the use of hydrogen fuel cells in maritime applications, marking the first step in confirming feasibility of hydrogen as a marine fuel. The hydrogen fuel cell system has been delivered from Korea and
New Study Finds Significant Correlation Between Masimo ORi™ and Arterial Partial Pressure of Oxygen During One-Lung Ventilation11.12.2023 08:00:00 CET | Press release
Masimo (NASDAQ: MASI) today announced the findings of a retrospective study published in the Journal of Anesthesia in which Dr. Yu Jeong Bang and colleagues at the Samsung Medical Center, Sungkyunkwan University School of Medicine, in Seoul, South Korea, investigated the association of Masimo ORi™ and the arterial partial pressure of oxygen (PaO2) in 554 patients who underwent non-cardiac thoracic surgery during one-lung ventilation (OLV), making this study the largest to date on ORi. The researchers found that ORi values “were significantly correlated with PaO2 measured simultaneously” and that ORi “could provide useful information on arterial oxygenation even during one-lung ventilation.”1 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231210873994/en/ Masimo Root® with ORi™ (Photo: Business Wire) Noninvasive, continuous Masimo ORi provides continuous, real-time insight into the oxygenation of hemoglobin in the moderate hy
Ferring and PharmaBiome Enter Into a New Microbiome R&D Collaboration and Exclusive Licensing Agreement11.12.2023 07:00:00 CET | Press release
Ferring Pharmaceuticals and Zürich-based microbiome translation company PharmaBiome are today announcing a research and development collaboration to drive forward new microbiome-based biotherapeutics in the field of gastroenterology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231210383233/en/ The deal provides Ferring with exclusive rights to develop, manufacture and commercialise next generation microbiome-based therapeutics within the field of gastroenterology arising out of the collaboration. The financial details of this deal are undisclosed. “This agreement is the latest in Ferring’s long term mission to maximise the therapeutic potential of the gut microbiome for the benefit of patients. PharmaBiome’s unique technology enables identification and manufacturing of defined consortium live microbiome biotherapeutics that could reverse microbiome dysbiosis linked to disease,” said Carl Bilbo, Senior Vice President, Micr